Lyon, France

Romain Debret

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, University Claude Bernard - Lyon 1. Active years: 2021.


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romain Debret: Innovator in Biocompatible Materials

Introduction

Romain Debret is a notable inventor based in Lyon, France. He has made significant contributions to the field of biocompatible materials, particularly through his innovative work on polypeptides derived from tropoelastin. His research has implications in biological and medical applications, especially in cell culture and tissue regeneration.

Latest Patents

Romain Debret holds a patent for a polypeptide derived from tropoelastin and a biocompatible material comprising the same. The invention provides a tropoelastin-derived polypeptide and an elastic composite biocompatible material that includes this polypeptide. The patent also outlines a method for synthesizing such a biocompatible material, which can be utilized as a cell culture support. This material is particularly valuable in the biological and medical fields, especially for applications in cell culture and tissue regeneration.

Career Highlights

Throughout his career, Romain Debret has worked with esteemed institutions such as the University Claude Bernard - Lyon 1 and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Romain has collaborated with notable colleagues, including Jérôme Sohier and Pascal Sommer. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Romain Debret is a distinguished inventor whose work on biocompatible materials has the potential to revolutionize the fields of biology and medicine. His contributions, particularly in the area of tropoelastin-derived polypeptides, highlight the importance of innovation in advancing medical technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…